Thus, unless there is prior evidence of low necrotic death following drug treatment, which is the case for 5-FU treatment of RIF-1 tumours in vivo (Aboagye et al, 1998), changes in radiolabelled annexin V binding should be interpreted as changes in cell death rather than changes in apoptosis. The gene discussed is ANXA5; the disease is neoplasm.